Treatment with CDK4/6 inhibitors can induce senescence in specific cancer cells, including oestrogen receptor (ER)‐positive breast cancer, lung cancer, melanomas and liposarcoma.19, 44, 45, 46, 47, 48. This evidence concerns the gene CDK4 and melanoma.